The observed significant inhibition of TNF-α and chemokine (IL-8 and MCP-1) production is of special interest for treating inflammatory diseases such as rheumatic arthritis, respiratory diseases, and arteriosclerosis. This evidence concerns the gene CXCL8 and arteriosclerosis.